XTX Topco’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

XTX Topco’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702K	Buy	+91,100	New	+$1.23M	0.01%	2111

Other funds holding LABD

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

XTX Topco's LABD Position: Q2 2026 in Review

XTX Topco opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 91,100 shares worth $702K. The stake represents 0.01% of the portfolio and ranks #2111 among its holdings.

21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

XTX Topco held 91,100 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $702K as of Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF was a new XTX Topco position in Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2111 holding.
21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.